| PIK3CA (p110a) | PIK | Atypical | 8exo | A | B | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | 14534 | 0.42 | |
| PIK3CA (p110a) | PIK | Atypical | 8exl | A | A | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 14537 | 1.00 | |
| PIK3CA (p110a) | PIK | Atypical | 8exo | A | A | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | 14541 | 0.42 | |
| PIK3CA (p110a) | PIK | Atypical | 8exv | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14542 | 0.40 | |
| PIK3CG (p110g) | PIK | Atypical | 6aud | A | B | 10-[(s)-(1-tert-butylpiperidin-4-yl)sulfinyl]-2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine | Human | 9216 | 0.42 | |
| PIK3CG (p110g) | PIK | Atypical | 6aud | A | A | 10-[(s)-(1-tert-butylpiperidin-4-yl)sulfinyl]-2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine | Human | 9239 | 0.42 | |
| PIK3CD (p110d) | PIK | Atypical | 5dxu | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 9091 | 0.51 | |
| PIK3CA (p110a) | PIK | Atypical | 8tgd | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14970 | 0.40 | |
| PIK3CA (p110a) | PIK | Atypical | 8tdu | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14969 | 0.40 | |
| PIK3CD (p110d) | PIK | Atypical | 5t8f | A | | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 9093 | 1.00 | |
| PIK3CA (p110a) | PIK | Atypical | 8tdu | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14967 | 0.40 | |
| PIK3CA (p110a) | PIK | Atypical | 8am0 | A | | (2r)-2-[[2-[(4s)-4-[bis(fluoranyl)methyl]-2-oxidanylidene-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide | Human | 15083 | 0.40 | |
| PIK3CA (p110a) | PIK | Atypical | 5dxt | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 9299 | 0.51 | |
| PIK3CA (p110a) | PIK | Atypical | 8exl | A | B | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 14536 | 1.00 | |
| PIK3CA (p110a) | PIK | Atypical | 8exv | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14538 | 0.40 | |
| PIK3CA (p110a) | PIK | Atypical | 8tgd | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14972 | 0.40 | |
Match: